Trial Profile
Single Blind, Multi-center, Post Marketing Clinical Study of Zolpidem (Myslee) in Adolescent Patients With Insomnia - Evaluation With Polysomnography.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2017
Price :
$35
*
At a glance
- Drugs Zolpidem (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 09 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2010 Planned end date changed from Jan 2010 to Mar 2010 as reported by ClinicalTrials.gov.
- 10 Mar 2010 Planned number of patients changed from 10 to 15 as reported by ClinicalTrials.gov.